EBOS Group Limited (AU:EBO) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
EBOS Group Limited has announced the appointment of Matthew Muscio as a director effective January 1, 2025. Muscio, who previously served as CEO of EBOS Medical Technology, holds 33,687 performance rights in the company. This strategic move may influence EBOS’s presence in the medical technology sector.
For further insights into AU:EBO stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue